loader image
Saturday, February 14, 2026
72.2 F
McAllen
- Advertisement -

The Texas Medical Association Applauds Trump Appointment to HHS

Translate to Spanish or other 102 languages!

Rep. Tom Price (R-Ga.), a veteran lawmaker and vehement critic of the Affordable Care Act, has been picked as President-elect Donald Trump's choice to lead the Department of Health and Human Services.
Rep. Tom Price (R-Ga.), a veteran lawmaker and vehement critic of the Affordable Care Act, has been picked as President-elect Donald Trump’s choice to lead the Department of Health and Human Services.

Mega Doctor News

- Advertisement -

Statement by Texas Medical Association (TMA) President Don R. Read, MD, on President-Elect Donald Trump’s announcement that he will appoint U.S. Rep. Tom Price, MD, of Georgia as secretary of the Department of Health and Human Services (HHS).

“The physicians of Texas are extremely pleased by President-Elect Donald Trump’s announcement this morning that he will appoint Rep. Tom Price, an orthopedic surgeon, to be the new U.S. secretary of health and human services.

“Dr. Price is a problem-solver by nature, and he is committed to addressing many intractable problems that get in the way of physicians caring for our patients. For years, he has targeted government programs like the Physician Quality Reporting System and the misnamed meaningful use program. These and many other federal regulations are no more than paper-pushing exercises that do nothing to improve quality of care.

- Advertisement -

“We look forward to working with Dr. Price to clear away these time-sucking obstacles to good patient care.”

TMA is the largest state medical society in the nation, representing more than 49,000 physician and medical student members. It is located in Austin and has 110 component county medical societies around the state. TMA’s key objective since 1853 is to improve the health of all Texans.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Breakthrough TTFields Technology Gets FDA Approval for Pancreatic Cancer Treatment

Mega Doctor News The U.S. Food and Drug Administration has approved a...

El Paso Researchers Advance New Treatments for Cancer and Heart Disease

Ramadevi Subramani Reddy, Ph.D., remembers the neem tree from her childhood in India — a plant her grandmother used to treat everything from fevers to infections.

STHS Heart Celebrates 30 Years of Cardiovascular Excellence

On January 15, 1996, South Texas Health System (STHS) Heart—then named McAllen Heart Hospital—opened as one of the...

Unexpected Cancer Drug Combo Shows Stronger Results Against Ovarian Tumors

A new study published by Mayo Clinic researchers suggests that ovarian cancer cells quickly activate a survival response after PARP inhibitor treatment, and blocking this early response may make this class of drugs work better.
- Advertisement -
×